Skip to main content
Premium Trial:

Request an Annual Quote

A Conversation Piece at the Least

A Dutch design studio is putting on an exhibition of DNA-inspired furniture and jewelry, Wired reports. The studio, called Tjep., is working in conjunction with Eric Wolthuis at DutchDNA to obtain genetic profiles which they then map using 3D imaging and turn into a furniture design that "literally capture a person's essence and stand as unique pieces of art," Wired says.

Frank Tjepkema from Tjep. starts with saliva sample that is analyzed at 16 variable markers that he feeds into a design program he created to develop a visual depiction of the DNA pattern, Wired writes. Both a 3D and 2D image of the DNA is used to inform his design of the piece.

"When I was asked to work with an abstract series of numbers I was thrown back into a world without cultural references and this was actually quite liberating," Tjepkema tells Wired. "I had an excuse to make something abstract within a given conceptual framework. The resulting designs are either completely abstract, in which case the data itself was source of inspiration or a combination of a symbolic reference."

NPR's The Two-Way adds that Tjep. is to exhibit this line in Milan, Italy, later this month and after then, it will be taking commissioned projects. "[I]f Ikea isn't cutting it and you want a genetically inspired bed, table or desk, this is your chance," NPR adds. Prices, it notes, have not been set.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more